| Cat No | Product Name / Activity |
|---|---|
| 2301 | T 0070907 |
| Highly potent and selective covalent PPARγ antagonist | |
| 2302 | Sanguinarine chloride |
| Inhibitor of protein phosphatase 2C (PP2C) | |
| 2303 | PNU 282987 |
| Selective α7 nAChR agonist | |
| 2304 | Devazepide |
| Selective, orally active CCK1 receptor antagonist | |
| 2305 | Tautomycetin |
| Selective PP1 inhibitor | |
| 2306 | 15-deoxy-Δ-12,14-Prostaglandin J2 |
| Endogenous PPARγ agonist | |
| 2307 | Leukotriene B4 |
| BLT1/BLT2 receptor agonist and potent chemotactic factor | |
| 2308 | Tabimorelin hemifumarate |
| Potent, orally active ghrelin receptor agonist | |
| 2309 | SR 142948 |
| Highly potent NT receptor antagonist | |
| 2310 | SR 49059 |
| Selective, orally active vasopressin V1A receptor antagonist | |
| 2311 | L-168,049 |
| Potent, orally active human glucagon receptor antagonist | |
| 2312 | DNQX disodium salt |
| Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
| 2313 | QX 314 chloride |
| Na+ channel blocker | |
| 2314 | LOE 908 hydrochloride |
| Broad spectrum cation channel blocker; neuroprotective | |
| 2315 | Immethridine dihydrobromide |
| Potent H3 agonist, highly selective over H4 | |
| 2316 | AMG 9810 |
| Potent and selective, competitive antagonist of TRPV1 | |
| 2318 | Pravastatin sodium salt |
| HMG-CoA reductase inhibitor | |
| 2319 | CALP2 |
| Cell-permeable calmodulin antagonist | |
| 2320 | TCS 184 |
| Scrambled control peptide for use with TCS 183 (Cat. No. 2236) | |
| 2321 | CALP3 |
| Cell-permeable calmodulin agonist | |
| 2322 | BTS 54-505 hydrochloride |
| Potent SNRI; active metabolite of sibutramine (Cat. No. 2290) | |
| 2324 | Necrostatin-1 |
| RIPK1 inhibitor; inhibits necroptosis | |
| 2329 | Ro 10-5824 dihydrochloride |
| Selective D4 receptor partial agonist | |
| 2330 | DMP 543 |
| Potent, orally active ACh release enhancer | |
| 2332 | (+)-Igmesine hydrochloride |
| Selective σ1 ligand; antidepressant | |
| 2333 | JNJ 16259685 |
| Highly potent, mGlu1-selective non-competitive antagonist | |
| 2337 | Trequinsin hydrochloride |
| Extremely potent inhibitor of PDE3 | |
| 2338 | MK 571 |
| Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor | |
| 2339 | WEB 2086 |
| Potent PAF receptor antagonist | |
| 2341 | A 80426 mesylate |
| High affinity α2 antagonist. Also 5-HT uptake inhibitor | |
| 2342 | 4-Methylhistamine dihydrochloride |
| Selective, high affinity H4 agonist | |
| 2344 | CGH 2466 dihydrochloride |
| A1, A2B and A3 antagonist and inhibitor of p38 MAPK and PDE4 | |
| 2345 | ZK 200775 |
| Competitive non-NMDA iGluR antagonist | |
| 2347 | Salubrinal |
| Selective inhibitor of eIF2α dephosphorylation | |
| 2348 | Gavestinel |
| Potent and selective NMDA antagonist; acts at the glycine site | |
| 2349 | Dihydro-β-erythroidine hydrobromide |
| α4β2, muscle type and Torpedo nAChR antagonist | |
| 2370 | Bombinakinin-GAP |
| Bioactive, bradykinin-related peptide | |
| 2371 | Bombinakinin M |
| Potent bradykinin receptor agonist | |
| 2372 | ABT 702 dihydrochloride |
| Adenosine kinase inhibitor; orally active | |
| 2373 | T 0901317 |
| Potent liver X receptor (LXR) agonist; also CAR inverse agonist | |
| 2374 | GW 405833 |
| Selective, high affinity CB2 receptor partial agonist | |
| 2382 | EMD 386088 hydrochloride |
| Potent 5-HT6 agonist | |
| 2383 | Bryostatin 1 |
| Protein kinase C activator | |
| 2385 | AMN 082 dihydrochloride |
| Selective mGlu7 agonist | |
| 2386 | Fenobam |
| Potent and selective mGlu5 antagonist | |
| 2387 | LY 320135 |
| Selective CB1 inverse agonist | |
| 2390 | LY 456236 hydrochloride |
| Selective mGlu1 antagonist | |
| 2391 | Astressin 2B |
| Selective CRF2 antagonist | |
| 2392 | JTE 013 |
| S1P2 receptor antagonist | |
| 2394 | SDZ NKT 343 |
| Highly selective human NK1 antagonist | |
| 2395 | Sertraline hydrochloride |
| 5-HT re-uptake inhibitor | |
| 2396 | Glimepiride |
| Kir6 (KATP) channel blocker | |
| 2397 | Eplerenone |
| Selective mineralocorticoid receptor antagonist | |
| 2398 | SNAP 5089 |
| Subtype-selective α1A antagonist |